176 related articles for article (PubMed ID: 14525974)
1. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF
J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974
[TBL] [Abstract][Full Text] [Related]
2. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.
Gomez D; Lemarteleur T; Lacroix L; Mailliet P; Mergny JL; Riou JF
Nucleic Acids Res; 2004; 32(1):371-9. PubMed ID: 14729921
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence.
Douarre C; Gomez D; Morjani H; Zahm JM; O'donohue MF; Eddabra L; Mailliet P; Riou JF; Trentesaux C
Nucleic Acids Res; 2005; 33(7):2192-203. PubMed ID: 15831792
[TBL] [Abstract][Full Text] [Related]
4. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
[TBL] [Abstract][Full Text] [Related]
5. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
6. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
7. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.
Riou JF; Guittat L; Mailliet P; Laoui A; Renou E; Petitgenet O; Mégnin-Chanet F; Hélène C; Mergny JL
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2672-7. PubMed ID: 11854467
[TBL] [Abstract][Full Text] [Related]
8. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
[TBL] [Abstract][Full Text] [Related]
9. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
[TBL] [Abstract][Full Text] [Related]
11. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
[TBL] [Abstract][Full Text] [Related]
12. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
Steenbergen RD; Kramer D; Meijer CJ; Walboomers JM; Trott DA; Cuthbert AP; Newbold RF; Overkamp WJ; Zdzienicka MZ; Snijders PJ
J Natl Cancer Inst; 2001 Jun; 93(11):865-72. PubMed ID: 11390536
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
15. Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
[TBL] [Abstract][Full Text] [Related]
16. Reversible manipulation of telomerase expression and telomere length. Implications for the ionizing radiation response and replicative senescence of human cells.
Rubio MA; Kim SH; Campisi J
J Biol Chem; 2002 Aug; 277(32):28609-17. PubMed ID: 12034742
[TBL] [Abstract][Full Text] [Related]
17. Administration with telomeric DNA telomere-like oligonucleotides induces enhancement of telomerase activity and resistance against oxidative stress in telomere reverse transcriptase gene-transfected human fibroblasts.
Watanabe S; Saitoh Y; Namba M; Miwa N
Biomed Pharmacother; 2010 Oct; 64(8):565-71. PubMed ID: 20347571
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
[TBL] [Abstract][Full Text] [Related]
19. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
Jiang F; Bao J; Li P; Nicosia SV; Bai W
J Biol Chem; 2004 Dec; 279(51):53213-21. PubMed ID: 15485861
[TBL] [Abstract][Full Text] [Related]
20. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
Lantuejoul S; Soria JC; Morat L; Lorimier P; Moro-Sibilot D; Sabatier L; Brambilla C; Brambilla E
Clin Cancer Res; 2005 Mar; 11(5):2074-82. PubMed ID: 15756034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
